bpc-157 not approved for human use regulatory authority statement Peptides Lack Reliable Safety Information, Watchdog Warns FDA Compliance for Peptide Therapy

In certain embodiments, the small molecule cations of the invention may be accompanied by a counter anion (X )

Economic Sector Support (ESS) and Administration (Admin)

Chemical Makeup (1)(2)(3) Molecular formula Fragment 176-191 : C 78 H 125 N 23 O 23 S 2 CJC-1295 (Mod GRF 1-29) : C 152 H 252 N 44 O 42 Ipamorelin : C 38 H 49 N 9 O 5 Molecular weight Fragment 176-191 : 1817.12 g/mol CJC-1295 (Mod GRF 1-29) : 3367.9 g/mol Ipamorelin : 711.8 g/mol Other known titles Fragment 176-191: AOD 9604, GH (hGH) lipolytic fragment, Somatostatin (177-191), tyrosyl CJC-1295 : Mod GRF 1-29, CJC-1295 without DAC Ipamorelin Ipamorelin Acetate, IPA Research and Clinical Studies Fragment 176-191 & CJC-1295 & Ipamorelin Blend, and Growth Hormones While the fragment 176-191 appears to directly mimic the function of hGH, the peptides CJC-1295 and Ipamorelin appear to exert potential by upregulating the synthesis of hGH itself

Dosage Forms and Strengths: Methylcobalamin, Folic Acid, Niacinamide Injection is available as a sterile solution in vials containing specific concentrations of each vitamin component formulated for parenteral administration